RxSight, Inc. (RXST) Misses Q4 Earnings Estimates

Core Viewpoint - RxSight, Inc. reported quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.10 per share, representing a significant earnings surprise of -70% [1] - The company posted revenues of $40.21 million for the quarter ended December 2024, exceeding the Zacks Consensus Estimate by 0.07% and showing a year-over-year increase from $28.58 million [2] Financial Performance - The earnings report indicates a loss of $0.26 per share a year ago, highlighting an improvement in earnings despite missing estimates [1] - Over the last four quarters, the company has surpassed consensus EPS estimates two times and topped consensus revenue estimates four times [2] Stock Performance - RxSight shares have declined approximately 14.8% since the beginning of the year, contrasting with the S&P 500's gain of 1.7% [3] - The current Zacks Rank for RxSight is 4 (Sell), indicating expectations of underperformance in the near future [6] Future Outlook - The consensus EPS estimate for the upcoming quarter is $0.01 on revenues of $40.64 million, while the estimate for the current fiscal year is $0.27 on revenues of $190.95 million [7] - The outlook for the Medical - Instruments industry is favorable, ranking in the top 32% of over 250 Zacks industries, which may positively influence stock performance [8]